Skip to main content
AMRX
NASDAQ Life Sciences

Amneal Posts 6-Cent Loss Per Share in Third Quarter

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$20.226
Mkt Cap
$7.119B
52W Low
$10.06
52W High
$21.681
52W Position info
101% above low
Off High info
6.7% below high
Rel. Volume info
1.7× avg
Market data snapshot near publication time

AMRX has more than doubled off its 52-week low of $10.06.

Summary

Amneal reported a third-quarter loss of $21.7 million, or 6 cents per share, a negative print for a company that just posted strong Q2 results in August, while revenue came in at $862.7 million and adjusted EPS was 26 cents. The quarter is the first to include the Kashiv BioSciences acquisition closed August 10, so the loss likely reflects integration and deal-related costs layered onto the base business. The stock trades near $20 with a roughly $7 billion market cap, so a loss print against a profitable prior quarter is a meaningful swing in the near-term earnings story. The 8-K/A filed October 23 gave investors Kashiv's audited financials and pro forma results, setting the bar for this first combined quarter.

At the time of this announcement, AMRX was trading at $20.23 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $7.1B. The 52-week trading range was $10.06 to $21.68. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

AMRX - Latest Insights

AMRX
Nov 03, 2026, 6:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $20.20
Real-time Price: $19.20 info
Change: -$1.00 (-5%) info
Market Cap: $6.774B info
AMRX
Oct 23, 2026, 4:05 PM EDT
Filing Type: 8-K/A
Importance Score:
8
Price at Filing: $20.38
Real-time Price: $19.20 info
Change: -$1.18 (-6%) info
Market Cap: $6.774B info
AMRX
Sep 18, 2026, 4:01 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $18.71
Real-time Price: $19.20 info
Change: +$0.490 (+3%) info
Market Cap: $6.774B info
AMRX
Aug 12, 2026, 6:05 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $17.33
Real-time Price: $19.20 info
Change: +$1.87 (+11%) info
Market Cap: $6.774B info
AMRX
Aug 12, 2026, 6:04 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $17.33
Real-time Price: $19.20 info
Change: +$1.87 (+11%) info
Market Cap: $6.774B info